Contract research organization Inotiv Inc (NASDAQ: NOTV ) acquired Nashville, Tennessee-based Protypia Inc for $11 million .
Inotiv specializes in nonclinical and analytical drug discovery, development services, research models, and related products and services.
Protypia is a protein/peptide bioanalytical company offering high-quality, targeted tissue-based ... Full story available on Benzinga.com